Hydromorphone Alternatives Compared
Hydromorphone | Tramadol | Gabapentin |
|
---|
Hydromorphone | Tramadol | Gabapentin |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Hydromorphone is a morphine-like pain-relieving medicine that may be given to relieve severe pain that is not relieved by other pain-relieving treatments. It carries a high risk of respiratory... View more |
Prescription only
Tramadol is a strong pain relief medicine effective for both general and nerve-related pain. Tramadol can cause dependence and use may be limited by side effects such as nausea and... View more |
Prescription only
Gabapentin may be used in the treatment of partial-onset seizures and nerve pain but is likely to cause dizziness or drowsiness. Gabapentin enacarbil (brand name Horizant), a prodrug of gabapentin... View more |
Related suggestions Popular comparisons
|
|||||||||||||||||||||||
More about Hydromorphone | More about Tramadol | More about Gabapentin | ||||||||||||||||||||||||
Generic Status | ||||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Hydromorphone has an average rating of 8.0 out of 10 from a total of 441 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 14% reported a negative effect. |
Tramadol has an average rating of 6.8 out of 10 from a total of 1790 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 25% reported a negative effect. |
Gabapentin has an average rating of 7.1 out of 10 from a total of 2431 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 22% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: hydromorphone side effects in more detail. |
Commonly reported side effects include:
See also: tramadol side effects in more detail. |
Commonly reported side effects include:
See also: gabapentin side effects in more detail. |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all hydromorphone prices |
View all tramadol prices |
View all gabapentin prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Dilaudid | ConZip, Qdolo, Tramadol Hydrochloride ER | Fanatrex, Gabarone, Gralise, Neurontin | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
3.1 hours |
5.2 hours |
6 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 407 drugs are known to interact with hydromorphone:
|
A total of 648 drugs are known to interact with tramadol:
|
A total of 266 drugs are known to interact with gabapentin:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
May 12, 2014 |
August 29, 2011 |
October 06, 2011 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.